Clinical Presentation | Considerations for booster doses | CDC.Considerations for use of a COVID-19 vaccine booster dose | CDC.To clarify that a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.The use of each of the available COVID-19 vaccines as a heterologous (or “mix and match”) booster dose in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.18 through 64 years of age at high risk of severe COVID-19. The use of a single booster dose of the Pfizer/Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |